María Generosa
Crespo Leiro

2024

1. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

   European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 5-17

2. Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain

   Nefrologia

3. Diagnosing transthyretin amyloidosis in patients with known genetic cardiomyopathies - opportunities and open questions. Response

   Revista Espanola de Cardiologia

4. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy

   Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 347-349

5. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

   European Journal of Heart Failure, Vol. 26, Núm. 3, pp. 612-615

6. Focused update 2023 delle linee guida ESC 2021 per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico

   Giornale italiano di cardiologia (2006), Vol. 25, Núm. 3, pp. 202-213

7. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

   Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

8. Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure

   American Heart Journal, Vol. 267, pp. 52-61

9. Molecular states associated with dysfunction and graft loss in heart transplants

   Journal of Heart and Lung Transplantation, Vol. 43, Núm. 3, pp. 508-518

10. Predicting the development of heart failure in patients with atrial fibrillation

    Revista Espanola de Cardiologia

11. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

12. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

13. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia

14. Redefining the molecular rejection states in 3230 heart transplant biopsies: Relationships to parenchymal injury and graft survival

    American Journal of Transplantation

15. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

16. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

17. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

18. Use of SGLT2i in patients with transthyretin amyloid cardiomyopathy: prevalence and safety in a Spanish prospective cohort

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 349-352

19. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant

    Revista espanola de cardiologia (English ed.), Vol. 77, Núm. 1, pp. 39-49

20. Usefulness of remote pulmonary arterial pressure monitoring in patients with advanced heart failure listed for HT

    Revista Espanola de Cardiologia, Vol. 77, Núm. 6, pp. 493-495